Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications

Reactive oxygen species: Metabolism, oxidative stress, and signal transduction

Apel, K., & Hirt, H. (2004) · Annual Review of Plant Biology · doi:10.1146/annurev.arplant.55.031903.141701 · Cited by 11,723 · see citing works

Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity

Polazzi, E., Mengoni, I., Caprini, M., Peña‐Altamira, E., Kurtys, E., & Monti, B. (2012) · Neurosignals · doi:10.1159/000337115 · Cited by 9,023 · see citing works

Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases

Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455 · see citing works

Alzheimer's Disease: Genes, Proteins, and Therapy

Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063 · see citing works

2016 Alzheimer's disease facts and figures

Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069 · see citing works

Alzheimer’s disease

Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569 · see citing works

Hereditary Early-Onset Parkinson's Disease Caused by Mutations in <i>PINK1</i>

Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481 · see citing works

Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options

Uttara, B., Singh, A., Zamboni, P., & Mahajan, R. (2009) · Current Neuropharmacology · doi:10.2174/157015909787602823 · Cited by 3,378 · see citing works

Multiple Wearable Sensors in Parkinson and Huntington Disease Individuals: A Pilot Study in Clinic and at Home

Adams, J., Dinesh, K., Xiong, M., Tarolli, C. G., Sharma, S., Sheth, N., Aranyosi, A. J., Zhu, W. Y., Goldenthal, S. B., Biglan, K., et al. (2017) · Digital Biomarkers · doi:10.1159/000479018 · Cited by 3,190 · see citing works

Oxidative Stress, Caloric Restriction, and Aging

Sohal, R. S., & Weindruch, R. H. (1996) · Science · doi:10.1126/science.273.5271.59 · Cited by 3,133 · see citing works

Mitochondrial diseases in man and mouse

Wallace, D. C. (1999) · Science · doi:10.1126/science.283.5407.1482 · Cited by 3,060 · see citing works

Amyotrophic lateral sclerosis

Kiernan, M. C., Vucic, S., Cheah, B. C., Turner, M. R., Eisen, A., Hardiman, O., Burrell, J. R., & Zoing, M. C. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61156-7 · Cited by 2,603 · see citing works

A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease

Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380 · see citing works

Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo

Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336 · see citing works

Suppression of Reactive Oxygen Species and Neurodegeneration by the PGC-1 Transcriptional Coactivators

St-Pierre, J., Drori, S., Uldry, M., Silvaggi, J. M., Rhee, J., Jäger, S., Handschin, C., Zheng, K., Lin, J., Yang, W., et al. (2006) · Cell · doi:10.1016/j.cell.2006.09.024 · Cited by 2,233 · see citing works

Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation

Davies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., Ross, C. A., Scherzinger, E., Wanker, E. E., Mangiarini, L., & Bates, G. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80513-9 · Cited by 2,188 · see citing works

Decoding ALS: from genes to mechanism

Taylor, J. P., Brown, R. H., & Cleveland, D. W. (2016) · Nature · doi:10.1038/nature20413 · Cited by 2,047 · see citing works

The Role of Oxidative Stress in Parkinson's Disease

Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845 · see citing works

Huntington's disease: from molecular pathogenesis to clinical treatment.

Ross, C., & Tabrizi, S. (2011) · Lancet Neurology · doi:10.1016/s1474-4422(10)70245-3 · Cited by 1,693 · see citing works

The role of oxidative stress in neurodegenerative diseases

Kim, G. H., Kim, J. E., Rhie, S. J., & Yoon, S. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.4.325 · Cited by 1,355 · see citing works

Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease.

(2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.03.49 · Cited by 1,288 · see citing works

Inflammation in Neurodegenerative Disease—A Double-Edged Sword

Wyss-Coray, T., & Mucke, L. (2002) · Neuron · doi:10.1016/s0896-6273(02)00794-8 · Cited by 1,235 · see citing works

Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons

Nagai, M., Re, D. B., Nagata, T., Chalazonitis, A., Jessell, T. M., Wichterle, H., & Przedborski, S. (2007) · Nature Neuroscience · doi:10.1038/nn1876 · Cited by 1,220 · see citing works

Ferrostatins Inhibit Oxidative Lipid Damage and Cell Death in Diverse Disease Models

Skouta, R., Dixon, S. J., Wang, J., Dunn, D. E., Orman, M., Shimada, K., Rosenberg, P. A., Lo, D. C., Weinberg, J. M., Linkermann, A., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja411006a · Cited by 1,146 · cited 2× · see citing works

Systemic inflammation and disease progression in Alzheimer disease

Holmes, C., Cunningham, C., Zotova, E., Woolford, J., Dean, C., Kerr, S., Culliford, D., & Perry, V. H. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b6bb95 · Cited by 1,139 · see citing works

Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines

Panov, A. V., Gutekunst, C.-A., Leavitt, B. R., Hayden, M. R., Burke, J. R., Strittmatter, W. J., & Greenamyre, J. T. (2002) · Nature Neuroscience · doi:10.1038/nn884 · Cited by 1,030 · see citing works

Role of oxidative stress in Alzheimer’s disease

HUANG, W.-J., ZHANG, X., & CHEN, W.-W. (2016) · Biomedical Reports · doi:10.3892/br.2016.630 · Cited by 1,023 · see citing works

Transcriptional Repression of PGC-1α by Mutant Huntingtin Leads to Mitochondrial Dysfunction and Neurodegeneration

Cui, L., Jeong, H., Borovecki, F., Parkhurst, C. N., Tanese, N., & Krainc, D. (2006) · Cell · doi:10.1016/j.cell.2006.09.015 · Cited by 1,012 · see citing works

Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence

Hamer, M., & Chida, Y. (2009) · Psychological Medicine · doi:10.1017/s0033291708003681 · Cited by 988 · see citing works

Effects of Coenzyme Q10 in Early Parkinson Disease: Evidence of Slowing of the Functional Decline

Shults, C. W. (2002) · Archives of Neurology · doi:10.1001/archneur.59.10.1541 · Cited by 984 · see citing works

2011 Alzheimer's disease facts and figures

Alzheimer's Association (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.02.004 · Cited by 914 · see citing works

Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease

Zuccato, C., Valenza, M., & Cattaneo, E. (2010) · Physiological Reviews · doi:10.1152/physrev.00041.2009 · Cited by 848 · see citing works

Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier

Gilgun‐Sherki, Y., Melamed, E., & Offen, D. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00019-3 · Cited by 839 · see citing works

Environmental Risk Factors and Parkinson's Disease: Selective Degeneration of Nigral Dopaminergic Neurons Caused by the Herbicide Paraquat

McCormack, A. L., Thiruchelvam, M. J., Manning-Bog, A., Thiffault, C., Langston, J. W., Cory‐Slechta, D. A., & Monte, D. A. D. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0507 · Cited by 838 · see citing works

A YAC Mouse Model for Huntington’s Disease with Full-Length Mutant Huntingtin, Cytoplasmic Toxicity, and Selective Striatal Neurodegeneration

Hodgson, J., Agopyan, N., Gutekunst, C., Leavitt, B. R., LePiane, F. G., Singaraja, R. R., Smith, D. J., Bissada, N., McCutcheon, K. M., Nasir, J., et al. (1999) · Neuron · doi:10.1016/s0896-6273(00)80764-3 · Cited by 832 · see citing works

Mitochondria, oxidative stress and neurodegeneration

Federico, A., Cardaioli, E., Pozzo, P. D., Formichi, P., Gallus, G. N., & Radi, E. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.05.030 · Cited by 790 · see citing works

P1‐146: Chlamydia Pneumoniae‐Infected Astrocytes Alter Their Expression of Adam10, Bace1, and Presenilin‐1 Proteases

Al-Atrache, Z., Cader, A., & Appelt, D. M. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.06.894 · Cited by 765 · see citing works

Frataxin is Reduced in Friedreich Ataxia Patients and is Associated with Mitochondrial Membranes

Campuzano, V., Montermini, L., Lutz, Y., Cova, L., Hindelang, C., Jiralerspong, S., Trottier, Y., Kish, S. J., Faucheux, B. A., Trouillas, P., et al. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.11.1771 · Cited by 739 · see citing works

Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial

Lannfelt, L., Blennow, K., Zetterberg, H., Batsman, S., Ames, D., Harrison, J., Masters, C. L., Targum, S., Bush, A. I., Murdoch, R., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70167-4 · Cited by 725 · see citing works

Mitochondrial Defects and Oxidative Stress in Alzheimer Disease and Parkinson Disease

Yan, M. H., Wang, X., & Zhu, X. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.11.014 · Cited by 718 · see citing works

Genetics of Parkinson disease: paradigm shifts and future prospects

Farrer, M. J. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1831 · Cited by 709 · see citing works

Complexity of dopamine metabolism

Meiser, J., Weindl, D., & Hiller, K. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-34 · Cited by 665 · see citing works

Protein Oxidation in Aging and Age‐Related Diseases

Stadtman, E. R. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb05632.x · Cited by 660 · see citing works

Alzheimer's Disease Amyloid-β Binds Copper and Zinc to Generate an Allosterically Ordered Membrane-penetrating Structure Containing Superoxide Dismutase-like Subunits

Curtain, C. C., Ali, F. E. A., Volitakis, I., Cherny, R. A., Norton, R. S., Beyreuther, K. T., Barrow, C. J., Masters, C. L., Bush, A. I., & Barnham, K. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100175200 · Cited by 653 · see citing works

Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1α in Huntington's disease neurodegeneration

Weydt, P., Pineda, V. V., Torrence, A. E., Libby, R. T., Satterfield, T. F., Lazarowski, E. R., Gilbert, M. L., Morton, G. J., Bammler, T. K., Strand, A. D., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.10.004 · Cited by 562 · see citing works

Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.

de Rijk, M. C., Launer, L. J., Berger, K., Breteler, M. M. B., Dartigues, J. F., Baldereschi, M., Fratiglioni, L., Lobo, A., Martinez-Lage, J., Trenkwalder, C., et al. (2000) · PubMed · Cited by 528 · see citing works

Prevalence of Parkinson's disease in Europe : A collaborative study of population-based cohorts

de Rijk, M. C., Launer, L. J., Berger, K., Breteler, M. M. B., Dartigues, J. F., Baldereschi, M., Fratiglioni, L., Lobo, A., Martínez‐Lage, J. M., Trenkwalder, C., et al. (2000) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 514 · see citing works

Oxidative stress in Huntington’s disease

Browne, S. E., Ferrante, R. J., & Beal, M. F. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00216.x · Cited by 508 · see citing works

Oxidative stress in Alzheimer disease: A possibility for prevention

Bonda, D., Wang, X., Perry, G. L., Nunomura, A., Tabaton, M., Zhu, X., & Smith, M. A. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.04.005 · Cited by 481 · see citing works

Mitochondrial Dysfunction and Reactive Oxygen Species in Excitotoxicity and Apoptosis: Implications for the Pathogenesis of Neurodegenerative Diseases

Rego, A. C., & Oliveira, C. R. (2003) · Neurochemical Research · doi:10.1023/a:1025682611389 · Cited by 472 · see citing works

Risk factors for amyotrophic lateral sclerosis

Fang, F., Ingre, C., Roos, P. M., Kamel, F., & Piehl, F. (2015) · Clinical Epidemiology · doi:10.2147/clep.s37505 · Cited by 470 · see citing works

Production of Reactive Oxygen Species in Brain Mitochondria: Contribution by Electron Transport Chain and Non–Electron Transport Chain Sources

Adam-Vizi, V. (2005) · Antioxidants &amp; Redox Signaling · doi:10.1089/ars.2005.7.1140 · Cited by 439 · see citing works

Biological and physiological role of reactive oxygen species - the good, the bad and the ugly

Zuo, L., Zhou, T., Pannell, B. K., Ziegler, A. C., & Best, T. M. (2015) · Acta Physiologica · doi:10.1111/apha.12515 · Cited by 430 · see citing works

Neuroprotective strategies involving ROS in Alzheimer disease

Dumont, M., & Beal, M. F. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.11.026 · Cited by 402 · see citing works

Increased Iron and Free Radical Generation in Preclinical Alzheimer Disease and Mild Cognitive Impairment

Smith, M. A., Zhu, X., Tabaton, M., Liu, G., McKeel, D. W., Cohen, M. L., Wang, X., Siedlak, S. L., Dwyer, B. E., Hayashi, T., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1239 · Cited by 400 · see citing works

Neuroinflammation, oxidative stress, and the pathogenesis of Parkinson’s disease

Mosley, R. L., Benner, E. J., Kadiu, I., Thomas, M., Boska, M. D., Hasan, K. M., Laurie, C. D., & Gendelman, H. E. (2006) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2006.09.006 · Cited by 388 · see citing works

NLRP3 inflammasome is expressed and functional in mouse brain microglia but not in astrocytes

Gustin, A., Kirchmeyer, M., Koncina, E., Felten, P., Losciuto, S., Heurtaux, T., Tardivel, A., Heuschling, P., & Dostert, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130624 · Cited by 369 · see citing works

Huntington's disease: underlying molecular mechanisms and emerging concepts

Labbadia, J. P., & Morimoto, R. I. (2013) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2013.05.003 · Cited by 368 · see citing works

A central role for astrocytes in the inflammatory response to beta-amyloid; chemokines, cytokines and reactive oxygen species are produced.

Johnstone, M., Gearing, A., & Miller, K. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00226-4 · Cited by 353 · see citing works

Molecular mechanisms of cell death: central implication of ATP synthase in mitochondrial permeability transition

Bonora, M., Wieckowski, M. R., Chinopoulos, C., Kepp, O., Kroemer, G., Galluzzi, L., & Pinton, P. (2015) · Oncogene · doi:10.1038/onc.2014.96 · Cited by 330 · see citing works

Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis

D’Amico, E., Factor-Litvak, P. R., Santella, R. M., & Mitsumoto, H. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.06.029 · Cited by 324 · see citing works

Is SOD1 loss of function involved in amyotrophic lateral sclerosis?

Saccon, R. A., Bunton-Stasyshyn, R. K. A., Fisher, E., & Fratta, P. (2013) · Brain · doi:10.1093/brain/awt097 · Cited by 318 · see citing works

The Genetics of Parkinson Disease

Bekris, L. M., Mata, I. F., & Zabetian, C. P. (2010) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988710383572 · Cited by 307 · see citing works

Redox imbalance in Parkinson's disease

Chinta, S. J., & Andersen, J. K. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.02.005 · Cited by 302 · see citing works

Proteomic and oxidative stress analysis in human brain samples of Huntington disease

Sorolla, M. A., Reverter‐Branchat, G., Tamarit, J., Ferrer, I., Ros, J., & Cabiscol, E. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.05.014 · Cited by 300 · see citing works

Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease

Albers, D. S., & Beal, M. F. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6781-6_16 · Cited by 297 · see citing works

The Potential of HDAC Inhibitors as Cognitive Enhancers

Gräff, J., & Tsai, L. (2013) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140216 · Cited by 297 · see citing works

Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease

Ganguly, G., Chakrabarti, S., Chatterjee, U., & Saso, L. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s130514 · Cited by 295 · see citing works

Mitochondria: A therapeutic target in neurodegeneration

Moreira, P. I., Zhu, X., Wang, X., Lee, H., Nunomura, A., Petersen, R. B., Perry, G. L., & Smith, M. A. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.10.007 · Cited by 286 · see citing works

Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A 2 in cortical neurons

Shelat, P. B., Chalimoniuk, M., Wang, J., Strosznajder, J. B., Lee, J. C., Sun, A. Y., Simonyi, Á., & Sun, G. Y. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05347.x · Cited by 283 · see citing works

The wide spectrum of spinocerebellar ataxias (SCAs)

Manto, M. (2008) · Cerebellum · doi:10.1080/14734220510007914 · Cited by 281 · see citing works

Reactive Oxygen Species: Stuck in the Middle of Neurodegeneration

Patten, D. A., Germain, M., Kelly, M., & Slack, R. S. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100498 · Cited by 280 · see citing works

Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis

Etminan, M., Gill, S. S., & Samii, A. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70097-1 · Cited by 279 · see citing works

Mutant huntingtin and mitochondrial dysfunction

Bossy‐Wetzel, E., Petrilli, A. M., & Knott, A. B. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.09.004 · Cited by 269 · see citing works

Aβ and Tau Toxicities in Alzheimer's Are Linked via Oxidative Stress-Induced P38 Activation: Protective Role of Vitamin E

Giraldo, E., Lloret, A., Fuchsberger, T., & Viña, J. (2014) · Redox Biology · doi:10.1016/j.redox.2014.03.002 · Cited by 268 · cited 1× · see citing works

The critical role of methionine 35 in Alzheimer's amyloid β-peptide (1–42)-induced oxidative stress and neurotoxicity

Butterfield, D. A., & Debra Boyd-kimball, A. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.10.014 · Cited by 267 · see citing works

Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington’s disease transgenic mice

Pang, T. Y. C., Stam, N. C., Nithianantharajah, J., Howard, M. L., & Hannan, A. J. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.04.013 · Cited by 265 · see citing works

Nuclear factor erythroid 2-related factor 2 protects against beta amyloid

Kanninen, K. M., Malm, T., Jyrkkänen, H.-K., Goldsteins, G., Keksa-Goldsteine, V., Tanila, H., Yamamoto, M. P., Ylä‐Herttuala, S., Levonen, A., & Koıstınaho, J. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.07.010 · Cited by 256 · see citing works

Redox Roles of Reactive Oxygen Species in Cardiovascular Diseases

He, F. J., & Zuo, L. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161126059 · Cited by 240 · see citing works

Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis

Jiang, H., Ren, Y., Zhao, J., & Feng, J. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh180 · Cited by 239 · see citing works

Oxidative Stress and Huntington’s Disease: The Good, the Bad, and the Ugly

Kumar, A., & Ratan, R. R. (2016) · Journal of Huntington s Disease · doi:10.3233/jhd-160205 · Cited by 236 · see citing works

Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia

Lodi, R., Hart, P. E., Rajagopalan, B., Taylor, D. J., Crilley, J. G., Bradley, J. L., Blamire, A. M., Manners, D. N., Styles, P., Schapira, A. H. V., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1001 · Cited by 235 · see citing works

Environmental factors and unhealthy lifestyle influence oxidative stress in humans—an overview

Aseervatham, G. S. B., Thilagar, S., Jeyadevi, R., & Ananth, D. A. (2013) · Environmental Science and Pollution Research · doi:10.1007/s11356-013-1748-0 · Cited by 230 · see citing works

Pathogenic Mechanisms of a Polyglutamine-mediated Neurodegenerative Disease, Spinocerebellar Ataxia Type 1*

Zoghbi, H., & Orr, H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r800041200 · Cited by 228 · see citing works

Minocycline affects microglia activation, Aβ deposition, and behavior in APP‐tg mice

Seabrook, T. J., Jiang, L., Maier, M., & Lemere, C. A. (2006) · Glia · doi:10.1002/glia.20338 · Cited by 223 · see citing works

Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases

Nakamura, T., & Lipton, S. A. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.65 · Cited by 222 · see citing works

Energy deficit in Huntington disease: why it matters

Mochel, F., & Haller, R. G. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45691 · Cited by 220 · see citing works

The release of calcium from the endoplasmic reticulum induced by amyloid-beta and prion peptides activates the mitochondrial apoptotic pathway

Ferreiro, E. B., Oliveira, C. R., & Pereira, C. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.02.003 · Cited by 219 · see citing works

Oxidative damage to mitochondrial DNA in Huntington's disease parietal cortex

Polidori, M. C., Mecocci, P., Browne, S. E., Senin, U., & Beal, M. F. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00578-9 · Cited by 211 · see citing works

A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson's disease

Fahn, S. (1992) · Annals of Neurology · doi:10.1002/ana.410320722 · Cited by 211 · see citing works

DATATOP: A decade of neuroprotective inquiry

Shoulson, I., & Parkinson Study Group (1998) · Annals of Neurology · doi:10.1002/ana.410440724 · Cited by 202 · see citing works

NADPH oxidase as a therapeutic target in Alzheimer's disease

Block, M. L. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-s2-s8 · Cited by 202 · see citing works

The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease

Zuo, L., & Motherwell, M. S. (2013) · Gene · doi:10.1016/j.gene.2013.07.085 · Cited by 194 · see citing works

Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington’s disease gene carriers and healthy subjects

Klepac, N., Relja, M., Klepac, R., Hecimovic, S. K., Babić, T., & Trkulja, V. (2007) · Journal of Neurology · doi:10.1007/s00415-007-0611-y · Cited by 181 · see citing works

The Ginkgo biloba extract EGb 761 rescues the PC12 neuronal cells from β-amyloid-induced cell death by inhibiting the formation of β-amyloid-derived diffusible neurotoxic ligands

Yao, Z., Drieu, K., & Papadopoulos, V. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03131-0 · Cited by 181 · see citing works

Occupational and environmental exposure to pesticides and cytokine pathways in chronic diseases (Review)

Gangemi, S., Gofiţă, E., Costa, C., Teodoro, M., Briguglio, G., Nikitovic, D., Tzanakakis, G. N., Tsatsakis, A. M., Wilks, M. F., Spandidos, D. A., et al. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2728 · Cited by 181 · see citing works

On the Relation of Oxidative Stress to Neuroinflammation: Lessons Learned from the G93A-SOD1 Mouse Model of Amyotrophic Lateral Sclerosis

Hensley, K., Mhatre, M., Mou, S., Pye, Q. N., Stewart, C. A., West, M. S., & Williamson, K. S. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.2075 · Cited by 168 · see citing works

The Cu, Zn Superoxide Dismutase: Not Only a Dismutase Enzyme

Mondola, P., Damiano, S., Sasso, A., & Santillo, M. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00594 · Cited by 166 · see citing works

Reprint of: Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease—resemblance to the effect of amphetamine drugs of abuse

Perfeito, R., Cunha‐Oliveira, T., & Rego, A. C. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.042 · Cited by 165 · see citing works

Erratum: Molecular mechanisms of cell death: central implication of ATP synthase in mitochondrial permeability transition

Bonora, M., Wieckowsk, M. R., Chinopoulos, C., Kepp, O., Kroemer, G., Galluzzi, L., & Pinton, P. (2015) · Oncogene · doi:10.1038/onc.2014.462 · Cited by 163 · see citing works

Astrocytes and Microglia as Non-cell Autonomous Players in the Pathogenesis of ALS

Lee, J.-H., Hyeon, S. J., Im, H., Ryu, H., Kim, Y., & Ryu, H. (2016) · Experimental Neurobiology · doi:10.5607/en.2016.25.5.233 · Cited by 155 · see citing works

DATATOP: a decade of neuroprotective inquiry. Parkinson Study Group. Deprenyl And Tocopherol Antioxidative Therapy Of Parkinsonism.

Shoulson, I. (1998) · PubMed · Cited by 154 · see citing works

Isoprostanes and Neuroprostanes as Biomarkers of Oxidative Stress in Neurodegenerative Diseases

Miller, E. D., Morel, A., Saso, L., & Saluk, J. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/572491 · Cited by 154 · see citing works

Antioxidants as therapies: can we improve on nature?

Murphy, M. P. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.04.010 · Cited by 148 · see citing works

Acetyl-l-carnitine and α-lipoic acid affect rotenone-induced damage in nigral dopaminergic neurons of rat brain, implication for Parkinson's disease therapy

Zaitone, S. A., Abo–Elmatty, D. M., & Shaalan, A. A. M. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.09.002 · Cited by 141 · see citing works

Infantile-onset spinocerebellar ataxia and mitochondrial recessive ataxia syndrome are associated with neuronal complex I defect and mtDNA depletion

Hakonen, A. H., Goffart, S., Marjavaara, S. K., Paetau, A. E., Cooper, H., Mattila, K., Lampinen, M., Sajantila, A., Lönnqvist, T. R. I., Spelbrink, J. N., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn280 · Cited by 135 · see citing works

Autosomal dominant cerebellar ataxias: a systematic review of clinical features

Rossi, M., Perez‐Lloret, S., Doldan, L., et al. (2014) · European Journal of Neurology · doi:10.1111/ene.12350 · Cited by 134 · see citing works

Consensus Paper: Pathological Mechanisms Underlying Neurodegeneration in Spinocerebellar Ataxias

Matilla‐Dueñas, A., Ashizawa, T., Brice, A., Magri, S., McFarland, K. N., Pandolfo, M., Pulst, S. M., Rieß, O., Rubinsztein, D. C., Schmidt, J., et al. (2013) · The Cerebellum · doi:10.1007/s12311-013-0539-y · Cited by 128 · see citing works

The 2013 SFRBM Discovery Award: Selected discoveries from the Butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment

Butterfield, D. A. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.06.006 · Cited by 126 · see citing works

The effect of ageing on neurogenesis and oxidative stress in the APPswe/PS1deltaE9 mouse model of Alzheimer's disease

Hamilton, A., & Hölscher, C. (2012) · Brain Research · doi:10.1016/j.brainres.2012.02.015 · Cited by 121 · see citing works

Mitochondria and reactive oxygen and nitrogen species in neurological disorders and stroke: Therapeutic implications☆

Bolaños, J. P., Moro, M. Á., Lizasoaín, I., & Almeida, Á. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.009 · Cited by 119 · see citing works

The Role of Oxidative Stress-Induced Epigenetic Alterations in Amyloid-βProduction in Alzheimer’s Disease

Zuo, L., Hemmelgarn, B. T., Chuang, C., & Best, T. M. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/604658 · Cited by 118 · see citing works

Case-Control Study of Early Life Dietary Factors in Parkinson's Disease

Golbe, L. I., Farrell, T. M., & Davis, P. H. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520360068014 · Cited by 115 · see citing works

Oxidative stress and HNE conjugation of GLUT3 are increased in the hippocampus of diabetic rats subjected to stress

Reagan, L. P., Magariños, A. M., Yee, D. K., Swzeda, L. I., Bueren, A. M. V., McCall, A. L., & McEwen, B. S. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02212-5 · Cited by 114 · see citing works

Spinocerebellar ataxia: relationship between phenotype and genotype – a review

Sun, Y.-M., Lu, C., & Wu, Z.-Y. (2016) · Clinical Genetics · doi:10.1111/cge.12808 · Cited by 113 · see citing works

Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease—resemblance to the effect of amphetamine drugs of abuse

Perfeito, R., Cunha‐Oliveira, T., & Rego, A. C. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.08.569 · Cited by 108 · see citing works

Amyloid-beta causes apoptosis of neuronal cells via caspase cascade, which can be prevented by amyloid-beta-derived short peptides

Awasthi, A., Matsunaga, Y., & Yamada, T. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.08.001 · Cited by 102 · see citing works

The role of oxidative stress in Huntington’s disease: Are antioxidants good therapeutic candidates?

Gil-Mohapel, J., Brocardo, P., & Christie, B. (2014) · Current Drug Targets · doi:10.2174/1389450115666140115113734 · Cited by 101 · see citing works

Neuronal Death by Oxidative Stress Involves Activation of FOXO3 through a Two-Arm Pathway That Activates Stress Kinases and Attenuates Insulin-like Growth Factor I Signaling

Dávila, D., & Torres‐Alemán, I. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-08-0811 · Cited by 96 · see citing works

Alsin and SOD1G93A Proteins Regulate Endosomal Reactive Oxygen Species Production by Glial Cells and Proinflammatory Pathways Responsible for Neurotoxicity

Li, Q., Spencer, N. Y., Pantazis, N. J., & Engelhardt, J. F. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.279711 · Cited by 95 · see citing works

Important Role of Oxidative Stress Biomarkers in Huntington’s Disease

Túnez, I., Sánchez‐López, F., Agüera, E., Fernández‐Bolaños, R., Sánchez, F. M., & Tasset-Cuevas, I. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200605a · Cited by 93 · see citing works

Preventing Ca2+-mediated nitrosative stress in neurodegenerative diseases: Possible pharmacological strategies

Nakamura, T., & Lipton, S. A. (2010) · Cell Calcium · doi:10.1016/j.ceca.2009.12.009 · Cited by 92 · see citing works

The genetics of Parkinson's disease

de Silva, H. R. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00082-4 · Cited by 92 · see citing works

Mutational analysis of the Cu/Zn superoxide dismutase gene in a Catalan ALS population: Should all sporadic ALS cases also be screened for SOD1?

Gámez, J., Corbera‐Bellalta, M., Nogales‐Gadea, G., et al. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.03.006 · Cited by 82 · see citing works

Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson's disease patients

Pappert, E. J., Tangney, C., Goetz, C. G., Ling, Z. D., Lipton, J. W., Stebbins, G. T., & Carvey, P. M. (1996) · Neurology · doi:10.1212/wnl.47.4.1037 · Cited by 77 · see citing works

Overactivation of calcineurin induced by amyloid-beta and prion proteins

Agostinho, P. M., Lopes, J. P., Velez, Z., & Oliveira, C. R. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.01.005 · Cited by 76 · see citing works

Neurodegeneration in Alzheimer Disease: Role of Amyloid Precursor Protein and Presenilin 1 Intracellular Signaling

Nizzari, M., Thellung, S., Corsaro, A., Villa, V., Pagano, A., Porcile, C., Russo, C., & Florio, T. (2012) · Journal of Toxicology · doi:10.1155/2012/187297 · Cited by 70 · see citing works

Mitochondrial impairments contribute to Spinocerebellar ataxia type 1 progression and can be ameliorated by the mitochondria-targeted antioxidant MitoQ

Stucki, D., Ruegsegger, C., Steiner, S., Radecke, J., Murphy, M. P., Zuber, B., & Saxena, S. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.07.005 · Cited by 70 · see citing works

Motor neuron impairment mediated by a sumoylated fragment of the glial glutamate transporter EAAT2

Foran, E., Bogush, A. I., Goffredo, M., Roncaglia, P., Gustincich, S., Pasinelli, P., & Trotti, D. (2011) · Glia · doi:10.1002/glia.21218 · Cited by 66 · see citing works

Energy defects in Huntington's disease: Why “in vivo” evidence matters

Liot, G., Valette, J., Pépin, J., Flament, J., & Brouillet, E. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.065 · Cited by 65 · see citing works

Vitamin E and memantine in Alzheimer's disease: Clinical trial methods and baseline data

Dysken, M. W., Guarino, P., Vertrees, J. E., Asthana, S., Sano, M. C., Llorente, M. D., Pallaki, M., Love, S. B., Schellenberg, G. D., McCarten, J. R., et al. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.01.014 · Cited by 59 · see citing works

The Cu,Zn superoxide dismutase in neuroblastoma SK-N-BE cells is exported by a microvesicles dependent pathway

Mondola, P., Ruggiero, G., Serù, R., Damiano, S., Grimaldi, S., Garbi, C., Monda, M., Greco, D., & Santillo, M. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00583-1 · Cited by 57 · see citing works

Departments

(2000) · Neurology · doi:10.1212/wnl.54.11.21a · Cited by 57 · see citing works

New links between SOD1 and metabolic dysfunction from a yeast model of amyotrophic lateral sclerosis

Bastow, E. L., Peswani, A. R., Tarrant, D., et al. (2016) · Journal of Cell Science · doi:10.1242/jcs.190298 · Cited by 56 · see citing works

Characterization of reactive nitrogen species in allergic asthma

Zuo, L., Koozechian, M., & Chen, L. L. (2013) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2013.10.007 · Cited by 53 · see citing works

GLT1 overexpression in SOD1G93A mouse cervical spinal cord does not preserve diaphragm function or extend disease

Li, K., Hala, T. J., Seetharam, S., Poulsen, D. J., Wright, M. C., & Lepore, A. C. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.03.010 · Cited by 49 · see citing works

Beyond the redox imbalance: Oxidative stress contributes to an impaired GLUT3 modulation in Huntington's disease

Covarrubias‐Pinto, A., Moll, P., Solís‐Maldonado, M., Acuña, A. I., Riveros, A., Miró, M. P., Papic, E., Beltrán, F. A., Cepeda, C., Concha, I. I., et al. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.09.024 · Cited by 48 · see citing works

Medicinal Plants as Protective Strategies Against Parkinson's Disease

Mazo, N. A., Echeverrı́a, V., Cabezas, R., et al. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612823666170316142803 · Cited by 44 · see citing works

Secretion and Increase of Intracellular CuZn Superoxide Dismutase Content in Human Neuroblastoma SK-N-BE Cells Subjected to Oxidative Stress

Mondola, P., Annella, T., Serù, R., et al. (1998) · Brain Research Bulletin · doi:10.1016/s0361-9230(97)00438-3 · Cited by 43 · see citing works

Caspase substrates and neurodegenerative diseases

Bulat, N., & Widmann, C. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.07.007 · Cited by 41 · see citing works

Low P o 2conditions induce reactive oxygen species formation during contractions in single skeletal muscle fibers

Zuo, L., Shiah, A. A., Roberts, W. J., Chien, M. T., Wagner, P. D., & Hogan, M. C. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00563.2012 · Cited by 39 · see citing works

SuHeXiang Wan Essential Oil Alleviates Amyloid Beta Induced Memory Impairment Through Inhibition of Tau Protein Phosphorylation in Mice

Jeon, S., Hur, J., Jeong, H. J., Koo, B., & Pak, S. C. (2011) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x11009305 · Cited by 38 · see citing works

Cu,Zn superoxide dismutase increases intracellular calcium levels via a phospholipase C–protein kinase C pathway in SK-N-BE neuroblastoma cells

Mondola, P., Santillo, M., Serù, R., Damiano, S., Alvino, C. G., Ruggiero, G., Formisano, P., Terrazzano, G., Secondo, A., & Annunziato, L. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.131 · Cited by 35 · see citing works

BAG5 Interacts with DJ‐1 and Inhibits the Neuroprotective Effects of DJ‐1 to Combat Mitochondrial Oxidative Damage

Qin, L., Tan, J., Zhang, H., Kousar, R., Lu, J., Tang, J., Jiang, B., Shen, X., Guo, J., Tang, B., et al. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/5094934 · Cited by 30 · see citing works

Cu–Zn superoxide dismutase activates muscarinic acetylcholine M1 receptor pathway in neuroblastoma cells

Damiano, S., Petrozziello, T., Ucci, V., Amente, S., Santillo, M., & Mondola, P. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.11.001 · Cited by 29 · see citing works

Influence of intensive multifunctional neuro - rehabilitation on neuronal oxidative damage in patients with Huntington?s disease

Ciancarelli, I. (2015) · Functional Neurology · doi:10.11138/fneur/2015.30.1.047 · Cited by 28 · see citing works

Role of Physical Exercise as Complementary Treatment for Epilepsy and other Brain Disorders

Arida, R. M., Scorza, F. A., & Cavalheiro, É. A. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319380004 · Cited by 28 · see citing works

Function of SOD1, SOD2, and PI3K/AKT signaling pathways in the protection of propofol on spinal cord ischemic reperfusion injury in a rabbit model

Yu, Q. J., & Yang, Y. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.02.005 · Cited by 22 · see citing works

Neuroprotective effect of antioxidant compounds

Skouta, R. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.180738 · Cited by 8 · see citing works

An Overview of Oxidative Stress, Neuroinflammation, and Neurodegenerative Diseases

Teleanu, D. M., Niculescu, A.-G., Lungu, I. I., Radu, C. I., Vladâcenco, O., Roza, E., Costăchescu, B., Grumezescu, A. M., & Teleanu, R. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115938 · Cited by 1,085 · see citing works

Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease

Khan, S., Barve, K. H., & Kumar, M. S. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200528142429 · Cited by 820 · see citing works

Exercise-induced oxidative stress: Friend or foe?

Powers, S. K., Deminice, R., Ozdemir, M., Yoshihara, T., Bomkamp, M. P., & Hyatt, H. (2020) · Journal of Sport and Health Science · doi:10.1016/j.jshs.2020.04.001 · Cited by 655 · see citing works

Ageing, age-related diseases and oxidative stress: What to do next?

Luo, J., Mills, K., le Cessie, S., Noordam, R., & van Heemst, D. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100982 · Cited by 581 · see citing works

Health benefits of resveratrol: Evidence from clinical studies

Singh, A. P., Singh, R., Verma, S. S., Rai, V., Kaschula, C. H., Maiti, P., & Gupta, S. C. (2019) · Medicinal Research Reviews · doi:10.1002/med.21565 · Cited by 523 · see citing works

Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs

Naqvi, S., Panghal, A., & Flora, S. J. S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00494 · Cited by 305 · see citing works

Neuroprotective Natural Products for Alzheimer’s Disease

Chen, X., Drew, J., Berney, W., & Lei, W. (2021) · Cells · doi:10.3390/cells10061309 · Cited by 236 · see citing works

Oxidant/Antioxidant Imbalance in Alzheimer’s Disease: Therapeutic and Diagnostic Prospects

Wojsiat, J., Zoltowska, K. M., Laskowska-Kaszub, K., & Wojda, U. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6435861 · Cited by 221 · see citing works

The pleiotropic neuroprotective effects of resveratrol in cognitive decline and Alzheimer’s disease pathology: From antioxidant to epigenetic therapy

Griñán-Ferré, C., Bellver-Sanchis, A., Izquierdo, V., Corpas, R., Roig-Soriano, J., Chillón, M., Andres-Lacueva, C., Somogyvári, M., Sőti, C., Sanfeliu, C., et al. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101271 · Cited by 208 · see citing works

Neurotheranostics as Personalized Medicines

Kevadiya, B. D., Ottemann, B. M., Thomas, M. B., Mukadam, I., Nigam, S., McMillan, J., Gorantla, S., Bronich, T. K., Edagwa, B., & Gendelman, H. E. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.011 · Cited by 124 · see citing works

Exercise-Induced Neuroprotection and Recovery of Motor Function in Animal Models of Parkinson’s Disease

Palasz, E., Niewiadomski, W., Gasiorowska, A., Wysocka, A., Stepniewska, A., & Niewiadomska, G. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01143 · Cited by 95 · see citing works

Genome aging: somatic mutation in the brain links age-related decline with disease and nominates pathogenic mechanisms

Lodato, M. A., & Walsh, C. A. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz191 · Cited by 56 · see citing works

Antioxidant and Anti-Inflammatory Profiles of Spent Coffee Ground Extracts for the Treatment of Neurodegeneration

Angeloni, S., Freschi, M., Marrazzo, P., Hrelia, S., Beghelli, D., Juan-García, A., Juan, C., Caprioli, G., Sagratini, G., & Angeloni, C. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6620913 · Cited by 50 · see citing works

Neuroprotective effect of <i>Annona muricata</i>-derived polysaccharides in neuronal HT22 cell damage induced by hydrogen peroxide

Kim, W. S., Kim, Y.-E., Cho, E.-J., Byun, E.-B., Park, W. Y., Song, H.-Y., Kim, K., Park, S.-H., & Byun, E.-H. (2020) · Bioscience, Biotechnology, and Biochemistry · doi:10.1080/09168451.2020.1715201 · Cited by 37 · see citing works

Suppression of Alzheimer’s Disease-Like Pathology Progression by Mitochondria-Targeted Antioxidant SkQ1: A Transcriptome Profiling Study

Stefanova, N. A., Ershov, N. I., & Kolosova, N. G. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3984906 · Cited by 40 · see citing works

Tau‑targeting multifunctional nanocomposite based on tannic acid-metal for near-infrared fluorescence/magnetic resonance bimodal imaging-guided combinational therapy in Alzheimer's disease

Gu, Y., Zhang, Q., Huang, H., Ho, K. H. W., Zhang, Y., Yi, C., Zheng, Y., Chang, R. C. C., Wang, E. S., & Yang, M. (2024) · Theranostics · doi:10.7150/thno.98462 · Cited by 27 · see citing works

Beyond Antioxidant Effects: Nature-Based Templates Unveil New Strategies for Neurodegenerative Diseases

Bacci, A., Runfola, M., Sestito, S., & Rapposelli, S. (2021) · Antioxidants · doi:10.3390/antiox10030367 · Cited by 23 · see citing works

Intranasal Therapeutics for Neurodegenerative Disorders: Overcoming the Blood–Brain Barrier with Smart Formulations and Devices

Kumar, S., Yadav, A., Verma, R. K., Kumar, A., Gupta, P. K., & Shukla, R. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00386 · Cited by 14 · see citing works

Unraveling the link between neuropathy target esterase NTE/SWS, lysosomal storage diseases, inflammation, abnormal fatty acid metabolism, and leaky brain barrier

Tsap, M. I., Yatsenko, A. S., Hegermann, J., Beckmann, B., Tsikas, D., & Shcherbata, H. R. (2024) · eLife · doi:10.7554/elife.98020 · Cited by 8 · see citing works

Nature of Tau-Associated Neurodegeneration and the Molecular Mechanisms

Yang, Y., & Wang, J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170788 · Cited by 46 · see citing works

Disease-associated protein seeding suggests a dissociation between misfolded protein accumulation and neurodegeneration in prion disease

Alibhai, J. D., Diack, A. B., & Manson, J. C. (2017) · Prion · doi:10.1080/19336896.2017.1378289 · Cited by 5 · see citing works

A Possible Neurodegeneration Mechanism Triggered by Diabetes

Farhadi, A., Vosough, M., Zhang, J., Tahamtani, Y., & Shahpasand, K. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.07.012 · Cited by 31 · see citing works

Reactive oxygen species-mediated neurodegeneration is independent of the ryanodine receptor in Caernorhabditis elegans.

Young, L. E. A., & Williams, D. C. (2015) · PubMed · Cited by 3 · see citing works

Dihydroxy-Metabolites of Dihomo-gamma-linolenic Acid Drive Ferroptosis-Mediated NeurodegenerationPreprint

Sarparast, M., Pourmand, E., Hinman, J., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.05.522933 · Cited by 5 · see citing works